Fact CheckerSign in

NCT04392947Completed

Treatment of Major Depressive Disorder With Bilateral Theta Burst Stimulation

Source: ClinicalTrials.gov · Last updated 17 Sept 2025

Brief summary (registry, in English)

This is a randomized, double-blind, sham-controlled multicenter clinical trial. The aim is to provide evidence for efficacy of TBS in the treatment of patients with major depression. There will be a direct comparison between combined cTBS/iTBS with sham TBS. Overall, 236 patients with major depression will be randomized either to active TBS or sham TBS in a 1:1 ratio. The planned stimulation paradigms will be applied as add-on therapy to standard therapy (antidepressive medication and / or psychotherapy). Patients will receive 30 stimulation sessions in a 6-week treatment period (one session daily from Monday to Friday). Follow up assessments are scheduled 1 and 3 months after end of treatment period.

Status (registry)
Completed
Study type
Interventional
Enrollment
238 (actual)
First submitted
8 May 2020
Start date
29 Sept 2020
Primary completion date
28 May 2025
Lead sponsor
University Hospital Tuebingen
Diseases
Depression
NCT number
NCT04392947

What you commit to

  • Study type: Interventional
  • Participants enrolled: 238
  • From 29 Sept 2020 to the primary completion date, 28 May 2025
  • 7 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • antiepileptic drugs and/or benzodiazepines corresponding to \> 1mg lorazepam / day
  • previous rTMS treatment

Other illness

  • history of brain surgery, significant and clinically relevant brain malformation or neoplasm, head injury, stroke, dementia or other neurodegenerative disorder
  • history of seizures
  • lifetime history of non-response to adequate electroconvulsive therapy (minimum of eight treatments)
  • cardiac pacemakers, intracranial implant, or metal in the cranium

Other

  • acute suicidality (MADRS item 10 score \> 4)
  • deep brain stimulation
  • substance dependence or abuse in the past 3 months (with the exception of tobacco)
  • severe somatic comorbidity as judged by the study physician
  • pregnancy

Who the study is looking for

  • moderate or severe unipolar depression diagnosed according to criteria of Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5)
  • duration of the current episode must be ≥ 6 weeks and ≤ 2 years
  • HDRS17 ≥ 18
  • mild to moderate treatment resistance according to the Antidepressant Treatment History Form \[ATHF-SF\]. Treatment resistance is defined as having failed at least one but no more than three adequate antidepressant treatments in this episode
  • stable antidepressive medication 4 weeks before treatment or no antidepressive treatment
  • no further relevant psychiatric axis-I and/or axis-II disorder except for anxiety disorders (according to DSM-5 and SCID-5-PD)
  • no comorbid psychotic symptoms
  • ability to give consent

Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (7)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department of Psychiatry, Psychotherapy and Psychosomatics, Medical Faculty, University of Augsburg, Bezirkskrankenhaus Augsburg
Coordinator of this site? Confirm its status
AugsburgGermanyUnknown status
University of Leipzig, Dept. Psychiatry and Psychotherapy
Coordinator of this site? Confirm its status
LeipzigGermanyUnknown status
University of Munich
Coordinator of this site? Confirm its status
MunichGermanyUnknown status
University of Regensburg, Dept. Psychiatry and Psychotherapy
Coordinator of this site? Confirm its status
RegensburgGermanyUnknown status
University of Tuebingen, Dept Psychiatry and Psychotherapy
Coordinator of this site? Confirm its status
TübingenGermanyUnknown status
University of Um, Dept. Psychiatry and Psychotherapy
Coordinator of this site? Confirm its status
UlmGermanyUnknown status
University of Wuerzburg, Dept. Psychiatry and Psychotherapy
Coordinator of this site? Confirm its status
WürzburgGermanyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.